Status:
COMPLETED
Perioperative Administration of Pregabalin in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction
Lead Sponsor:
Prince of Songkla University
Conditions:
Postoperative Pain Management
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
To prove pregabalin's efficacy and safety in Thai patients scheduled for arthroscopic ACL reconstruction
Detailed Description
Only eligible patients with willingness to join this study are included. Eligible patients are those aged 18-65 years of either sex, American Society of Anesthesiologists (ASA) physical status I \& II...
Eligibility Criteria
Inclusion
- Eligible patients are those aged 18-65 years of either sex,
- American Society of Anesthesiologists (ASA) physical status I \& II, and body mass index (BMI) between 16-35.
Exclusion
- patients who are allergic to pregabalin,
- impaired hepatic and renal functions,
- alcohol or substance abuse,
- chronic pain (except pain in the knee joint) or daily intake of analgesics, uncontrolled medical disease (hypertension and diabetes mellitus)
- inability to operate patient-controlled analgesia (PCA) device
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01242332
Start Date
August 1 2009
End Date
October 1 2010
Last Update
November 17 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Prince of Songkla University
Hat Yai, Changwat Songkhla, Thailand, 90110